Rosuvastatin in African Americans With Cerebrovascular Disease "RIAA"


Phase 4 Results N/A

Summary of Purpose

This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA. Trial Stopped: loss of research personnel

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 November 2013.

1 Jan 2012 28 Oct 2013 1 Aug 2013 1 Aug 2013 1 Nov 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


Not available